Security Snapshot

NEW YORK LIFE INVESTMENTS ET - NYLI MERGER ARBI (MNA) Institutional Ownership

CUSIP: 45409B800

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

86

Shares (Excl. Options)

4,915,531

Price

$35.79

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / NYLI MERGER ARBI
Symbol
MNA
Price per share
$36.35
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
4,915,531
Total reported value
$175,941,299
% of total 13F portfolios
0%
Share change
+420,045
Value change
+$15,017,715
Number of holders
86
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • MNA - NEW YORK LIFE INVESTMENTS ET - NYLI MERGER ARBI is tracked under CUSIP 45409B800.
  • 86 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 86 to 56 between Q4 2025 and Q1 2026.
  • Reported value moved from $175,941,299 to $110,314,175.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 86 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 45409B800?
CUSIP 45409B800 identifies MNA - NEW YORK LIFE INVESTMENTS ET - NYLI MERGER ARBI in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 86 institutional investors reported holding 4,915,531 shares of NEW YORK LIFE INVESTMENTS ET - NYLI MERGER ARBI (MNA).

Institutional Holders of NEW YORK LIFE INVESTMENTS ET - NYLI MERGER ARBI (MNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 3,035,541 $110,314,175 -$5,439,570 $36.35 56
2025 Q4 4,915,531 $175,941,299 +$15,017,715 $35.79 86
2025 Q3 4,489,280 $161,156,281 +$9,591,016 $35.90 82
2025 Q2 4,286,273 $151,202,560 +$4,558,098 $35.27 73
2025 Q1 4,180,124 $143,390,530 -$9,024,282 $34.30 68
2024 Q4 4,448,094 $146,682,582 -$49,237,071 $32.96 72
2024 Q3 5,840,538 $192,031,908 -$75,652 $32.88 67
2024 Q2 5,845,270 $184,745,161 -$32,240,819 $31.60 70
2024 Q1 6,914,132 $217,722,959 -$63,529,262 $31.48 78
2023 Q4 8,931,060 $280,685,145 -$99,553,726 $31.41 90
2023 Q3 12,080,576 $381,599,700 +$1,712,060 $31.59 89
2023 Q2 12,025,008 $375,146,389 +$13,959,774 $31.20 94
2023 Q1 11,725,366 $370,809,818 -$22,662,634 $31.63 104
2022 Q4 12,485,270 $396,067,039 -$34,044,187 $31.73 117
2022 Q3 13,466,305 $421,354,556 +$19,939,254 $31.29 103
2022 Q2 13,132,755 $406,595,821 -$15,021,868 $30.96 105
2022 Q1 13,664,102 $436,323,770 -$94,618,315 $31.94 120
2021 Q4 16,729,334 $539,325,512 +$10,437,222 $32.25 120
2021 Q3 16,535,065 $543,604,050 -$5,721,590 $32.88 128
2021 Q2 16,708,487 $559,895,727 +$25,178,505 $33.52 126
2021 Q1 15,967,121 $522,377,431 +$5,780,818 $32.95 126
2020 Q4 15,718,733 $523,829,931 +$11,946,668 $33.33 125
2020 Q3 15,099,889 $505,430,936 +$3,457,256 $33.64 117
2020 Q2 15,139,776 $477,019,395 -$59,899,836 $31.53 120
2020 Q1 17,106,393 $515,791,835 -$57,851,600 $30.14 133
2019 Q4 19,065,350 $632,983,862 -$974,735 $33.20 140
2019 Q3 18,673,320 $598,853,305 -$110,808,699 $32.05 121
2019 Q2 22,207,255 $700,629,114 +$15,250,528 $31.55 130
2019 Q1 22,083,311 $704,921,329 +$151,118,816 $31.93 120
2018 Q4 17,384,115 $551,518,549 +$144,102,900 $31.71 111
2018 Q3 11,664,691 $370,561,054 +$49,313,132 $31.77 84
2018 Q2 10,271,183 $315,643,183 +$57,323,938 $30.71 71
2018 Q1 8,079,656 $248,360,693 +$100,586,154 $30.74 73
2017 Q4 4,811,215 $149,358,540 +$34,654,142 $31.05 66
2017 Q3 3,564,866 $109,832,088 +$12,712,987 $30.81 53
2017 Q2 3,218,354 $98,903,572 +$18,538,592 $30.74 51
2017 Q1 2,006,994 $60,211,265 +$9,044,409 $29.99 43
2016 Q4 1,711,815 $50,162,983 -$5,167,910 $29.30 42
2016 Q3 1,755,653 $51,263,000 -$7,861,966 $29.20 39
2016 Q2 2,039,659 $57,905,658 +$6,304,522 $28.43 39
2016 Q1 1,814,995 $52,432,560 +$545,661 $28.86 40
2015 Q4 1,770,155 $49,690,672 -$32,594,680 $28.07 41
2015 Q3 2,897,496 $80,577,548 -$1,575,396 $27.81 42
2015 Q2 2,954,849 $84,834,745 +$26,194,738 $28.71 37
2015 Q1 2,042,325 $58,936,435 +$24,157,734 $28.84 29
2014 Q4 1,223,446 $34,148,669 +$9,272,448 $27.91 28
2014 Q3 824,834 $22,630,329 +$11,887,739 $27.44 19
2014 Q2 391,167 $10,888,465 +$4,538,287 $27.82 15
2014 Q1 228,084 $6,217,267 +$622,248 $27.25 13
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .